IRCT20211118053093N5尚未招募2 期
Memantine augmentation of escitalopram in treatment of executive function among patients with OCD, a Double-blind placebo controlled randomized clinical trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- no limit 至 no limit（—）
- 性别
- All
入选标准
- •OCD diagnosis based on DSM-V criteria
- •Y-BOCS score equal or more than 18
排除标准
- •Medical problems
研究者
相似试验
已完成
3 期
Escitalopram ?s effectiveness on treatment of depressive disorder and improvement of quality of life in patients who are undergone coronary artery bypass graft surgeryIRCT20140126016374N2niversity of social welfare and rehabilitation sciences50
招募中
不适用
escitalopram in depressive patients with acute coronary artery syndromeMental and behavioral disordersKCT0000053Chonnam National University Hospital300
已完成
4 期
Role of Escitalopram Add-on in schizophrenia having subsyndromal depressive symptomsCTRI/2018/01/011551Pooja Singh66
进行中（未招募）
1 期
A Randomised Controlled Trial of Escitalopram and Nortriptyline compared with placebo, and standard psychological care, for depression in Parkinson’s diseaseDepression in Parkinson's diseaseMedDRA version: 20.0Level: PTClassification code 10012378Term: DepressionSystem Organ Class: 10037175 - Psychiatric disordersMedDRA version: 20.0Level: PTClassification code 10061536Term: Parkinson's diseaseSystem Organ Class: 10029205 - Nervous system disordersEUCTR2018-002942-35-GBniversity College London Comprehensive Clinical Trials Unit408
进行中（未招募）
不适用
Evaluation of the effect of escitalopram on cognitive and fine motor function in depressed elderly patients.EUCTR2006-002411-27-BEniversitair Psychiatrisch Centrum KU Leuven40